Skip to content
Sign in
Business opportunities for SisuSemi Ltd

Compatibility /100

34/100

Medium potential

Why talk

  1. Complementary sectors: Deep tech & materials × Biotech & life sciences — room for a joint offer or co-selling.
  2. SisuSemi Ltd likely needs funding for the next round — Pleryon Therapeutics (China, Series A, $18.6M raised) can offer investor introductions (inferred from public profile).
  3. Pleryon Therapeutics has raised about $18.6M — investor introductions are realistic.

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers12.5Market bridge3.8Customer potential0.0Sector synergy12.8Stage complementarity5.0

Dimension by dimension

Needs ↔ offers

12.5 / 25 pts

Pleryon Therapeutics can help SisuSemi Ltd.

  • SisuSemi Ltd likely needs funding for the next round — Pleryon Therapeutics (China, Series A, $18.6M raised) can offer investor introductions (inferred from public profile).

Market bridge

3.8 / 15 pts

Distant markets.

  • Pleryon Therapeutics is based in China (Asia): a landing pad on another continent, both ways.

Customer potential

0.0 / 40 pts

Neither side has a product on the market yet.

No supporting signal in the records.

Sector synergy

12.8 / 15 pts

Complementary sectors.

  • Complementary sectors: Deep tech & materials × Biotech & life sciences — room for a joint offer or co-selling.

Stage complementarity

5.0 / 5 pts

Strong mentoring / investor-intro potential.

  • Pleryon Therapeutics has raised about $18.6M — investor introductions are realistic.
  • Pleryon Therapeutics (Series A) is one step ahead of SisuSemi Ltd (Seed) — the freshest playbook for SisuSemi Ltd's next round.

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Customers”: Needs ↔ offers 25, Market bridge 15, Customer potential 40, Sector synergy 15, Stage complementarity 5. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 38/100 — high from 50, medium from 36.